Literature DB >> 35909099

Correction: hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.

Yan Su1,2,3,4, Xueyan Sun1,2,3,4, Xiao Liu1,2,3,4, Qingyuan Qu1,2,3,4, Liping Yang1,2,3,4, Qi Chen1,2,3,4, Fengqi Liu1,2,3,4, Yueying Li5,6, Qianfei Wang5,6, Bo Huang7, Xiao-Hui Zhang8,9,10,11, Xiao-Jun Huang12,13,14,15.   

Abstract

Entities:  

Year:  2022        PMID: 35909099      PMCID: PMC9339190          DOI: 10.1186/s13045-022-01323-2

Source DB:  PubMed          Journal:  J Hematol Oncol        ISSN: 1756-8722            Impact factor:   23.168


× No keyword cloud information.

Correction to: Journal of Hematology & Oncology (2022) 15:99 10.1186/s13045-022-01315-2

The original article [1] contained errors in the names of co-authors, Xiao-Jun Huang and Xiao-Hui Zhang which have since been corrected.
  1 in total

1.  hUC-EVs-ATO reduce the severity of acute GVHD by resetting inflammatory macrophages toward the M2 phenotype.

Authors:  Yan Su; Xueyan Sun; Xiao Liu; Qingyuan Qu; Liping Yang; Qi Chen; Fengqi Liu; Yueying Li; Qianfei Wang; Bo Huang; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  J Hematol Oncol       Date:  2022-07-21       Impact factor: 23.168

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.